Extreme Movers: DeepSeek's picks for 2026-09-24
DeepSeek picked BENF, SRZN, VSA, JAGX, BYND for a 1-day horizon. Average directional return: -6.36%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | DeepSeek |
| Prompt version | extreme-movers-v9 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-09-24 |
| Measured to | 2026-09-25 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -6.36% |
| Directions called correctly | 40% |
| Benchmark return | +0.67% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | BENF | down | +33.59% | -33.59% | 78% | -34.26% | No |
| 2 | SRZN | up | -7.92% | -7.92% | 74% | -8.59% | No |
| 3 | VSA | up | +15.17% | +15.17% | 70% | +14.50% | Yes |
| 4 | JAGX | down | +17.54% | -17.54% | 68% | -18.21% | No |
| 5 | BYND | down | -12.06% | +12.06% | 65% | +11.39% | Yes |
The model's market view
The September 24 session is characterized by extreme single-stock volatility driven by binary corporate events, while the broader market faces macro headwinds from rising Treasury yields above 5%. The highest-conviction setups are in names with substantive, verifiable catalysts that create sharp one-day moves independent of the market direction. Reverse stock splits, debt-restructuring announcements, and FDA regulatory decisions are producing the most violent price swings, and the most reliable continuation and reversal signals come from these event-driven names.
Why each pick
BENF
Beneficient surged 438.73% on September 23 to close at $2.90 after announcing a strategy to eliminate approximately $130 million in disputed debt and $850 million in preferred equity tied to its convicted former CEO. The catalyst is substantive and verifiable, but the move was clearly speculative and unsustainable: the stock gave back about 35% in premarket trading on September 24, falling to $1.89 (Prism MarketView, September 24). The company has not entered into a definitive agreement, and the proposed resolution remains subject to negotiations. I am selecting this as a reversal (direction down) because the one-day 438% spike is far beyond what the fundamental news justifies, and the premarket selling pressure signals that profit-taking has already begun. Reference price is the September 23 regular-session close of $2.90, sourced from Yahoo Finance Taiwan, as the most recent verifiable quote available at the time of answering.
SRZN
Surrozen fell 8.18% on September 23 to close at $16.16, but the stock surged over 97% in premarket trading on September 24 to $31.895 after announcing the submission of an IND application for SZN-8141 for the treatment of diabetic macular edema (GlobeNewswire via Yahoo Finance, September 24). The catalyst is substantive: the IND submission is a concrete regulatory milestone that moves the company's ophthalmology pipeline forward, and Surrozen has a Strong Buy consensus from 6 analysts with an average price target of $44.80 (stockanalysis.com, September 2026). I am selecting this as a reversal (direction up) because the stock fell in the source session but is indicated sharply higher on a substantive catalyst. Reference price is the September 24 premarket quote of $31.895, sourced from Sina Finance, the most recent live quote available.
VSA
VisionSys AI rose 83.84% on September 23 to close at $3.64, driven by growing investor appetite for AI infrastructure and machine vision plays. The catalyst is speculative rather than substantive: the company has faced a 99.91% year-over-year revenue decline, rendering its legacy vocational training operations effectively defunct, and its pivot into the Chinese K-12 STEM market and a proposed Solana treasury plan are unproven (VCPScanner, September 2026). The stock has a tiny market cap of approximately $10.23 million and a very small float, which amplifies volatility. I am selecting this as a continuation (direction up) because momentum-driven micro-cap AI names often extend gains for a second session, and the after-hours indication was positive. However, the lack of fundamental support makes this a high-risk pick. Reference price is the September 23 close of $3.64, sourced from eToro, the most recent verifiable quote.
JAGX
Jaguar Health plunged 74.14% on September 23 to close at $8.91, a sharp reversal from its 1,190% surge on Tuesday driven by FDA fee waivers for Mytesi and Canalevia-CA1 (Benzinga, September 23). The catalyst for the decline is substantive: the massive spike was driven by a one-time regulatory fee waiver that does not change the company's underlying financial profile, and profit-taking began immediately. The stock continued to fall about 25% in premarket trading on September 24 to $6.96 (Eastmoney, September 24). I am selecting this as a continuation (direction down) because the lack of fundamental support for the prior spike makes further downside the higher-probability outcome. Reference price is the September 23 close of $8.91, sourced from Yahoo Finance Taiwan, the most recent verifiable quote available.
BYND
Beyond Meat fell 12.86% on September 23 to close at $10.03, driven by two negative developments: a court ruling requiring the company to pay $15.4 million over trademark infringement and the agreement to retire about $15 million of convertible notes in exchange for stock, which could result in significant dilution (Business Insider, September 23; TradingView, September 23). The catalyst is substantive and negative: the convertible-note exchange could lead to the issuance of up to 848,000 shares, and the legal judgment adds to the company's financial strain. I am selecting this as a continuation (direction down) because the fundamental headwinds are unresolved and the stock has a Moderate Sell consensus with an average target of $10.00 (eToro, September 2026). Reference price is the September 23 close of $10.03, sourced from eToro, the most recent verifiable quote.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| GPT-5.6 Sol | BENF, WHLR, ARTL, JAGX, IPDN | -26.34% | 20% |
| Claude Opus 5 | IONQ, MCD, SECZ, AAON, DIS | +0.47% | 60% |
| Muse Spark 1.1 | GOOG, NVDA, SOXL, MSFT, IONQ | +2.73% | 80% |
| Gemini 1.5 Pro | EXPE, PAYX, MU, NVDA, SMR | +0.93% | 80% |
| Grok 4.5 | CRWD, PLTR, EXPE, ABNB, PAYX | +0.63% | 80% |
Written up on ForecastNest Insights: Extreme Movers: DeepSeek's picks for 2026-09-24.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.